Physician profile
Daniel V Harper
NPI 1053817916
$8,955.75
in general payments reported to CMS, 2019-2025
9 companies · $1,073 in 2025
The $1,073 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $17.02 · 2023: $4,296 · 2024: $3,570 · 2025: $1,073.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,257 · Food and Beverage: $2,681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,257.45 |
| Food and Beverage | $2,681.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $3,715.83 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $2,064.82 | 2023 | Indigo System, Penumbra System |
| Boston Scientific Corporation | $2,019.79 | 2023-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial), General - Therapies |
| Philips North America LLC | $584.38 | 2025 | Igt Devices Undivided, Technical Education Mri, IV Other |
| Terumo Medical Corporation | $186.46 | 2022-2025 | Azur Cx Detachable |
| Medtronic, INC. | $132.71 | 2023 | Kyphon Express II Kyphopak Tray |
| Galvanize Therapeutics, INC | $121.62 | 2023 | Aliya System |
| Stryker Corporation | $113.79 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bayer Healthcare Pharmaceuticals INC. | $16.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.